Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
This study has been completed.
Study NCT00039910   Information provided by Pfizer
First Received: June 14, 2002   Last Updated: May 3, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-Hodgkin Lymphoma
Hodgkin Disease
Thrombocytopenia
Additional conditions recognized in this trial
Lymphoma
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Blood Platelet Disorders
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
(PN-152,243)/ PN-196,444
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services